Incidence and severity of hypothyroidism and survival outcomes in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs).

Abstract

e15580 Background: Thyroid dysfunction is a common adverse effect of VEGF TKIs. There are conflicting reports on survival benefit in association with hypothyroidism. Moreover, severity of hypothyro...